Alternative splicing of the CAMKK2 exon 14 and/or 16 in human glioblastoma/astrocytoma cells [52] and exon 16 in rat neuroblastoma cells [53] has been reported. This evidence concerns the gene CAMKK2 and astrocytoma (excluding glioblastoma).